169 results on '"Strafella, Antonio P."'
Search Results
2. Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
3. Multiple system atrophy with amyloid-β predominant Alzheimer’s disease neuropathologic change
4. Metabolic imaging and plasticity
5. Combining transcranial brain stimulation and PET/SPECT molecular imaging
6. Covering Basic Needs on Molecular Imaging
7. PET imaging of synaptic density in Parkinsonian disorders
8. Tau in Atypical Parkinsonisms: A Meta‐Analysis of in vivo PET Imaging Findings
9. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s Disease
10. Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease
11. Structural and Molecular Imaging for Clinically Uncertain Parkinsonism
12. First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary Tale
13. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease
14. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
15. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
16. Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report
17. Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
18. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease
19. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
20. Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
21. Imaging pathological tau in atypical parkinsonisms: A review
22. Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson’s disease
23. Single‐Trajectory Multiple‐Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition
24. VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder
25. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease
26. VMAT2 Availability in Parkinson’s Disease with REM Sleep Behaviour Disorder
27. Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”
28. Changes in Metabolic Activity and Gait Function by Dual-Task Cognitive Game-Based Treadmill System in Parkinson’s Disease: Protocol of a Randomized Controlled Trial
29. Dopamine Receptors in Parkinson's Disease: A Meta‐Analysis of Imaging Studies
30. The neuroimaging evidence of brain abnormalities in functional movement disorders
31. Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals
32. Anxiety in Parkinson’s disease: Abnormal resting activity and connectivity
33. Extra‐striatal dopamine in Parkinson's disease with rapid eye movement sleep behavior disorder
34. Functional Imaging of Dopaminergic Neurotransmission in Tourette Syndrome
35. Graph theory analysis of the dopamine D2 receptor network in Parkinson’s disease patients with cognitive decline
36. A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study
37. Brain Activation Studies in Parkinson’s Disease
38. Neurobiology of Impulse Control Disorders in Parkinson's Disease
39. Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
40. Disease modification and biomarker development in Parkinson disease
41. Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study
42. Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease
43. Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
44. Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders
45. Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
46. The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
47. The clinical significance of lower limb tremors
48. Dynamic functional connectivity changes associated with dementia in Parkinson’s disease
49. Imaging tools to map in vivo the human brain
50. PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.